Interview with Robin Rumler, CEO, Pfizer Austria
Dr. Rumler, what is your assessment of the subsidiary’s current strengths and weaknesses, after three and half years of tenure? Pfizer currently ranks second in the overall pharmaceutical market in…
Address: IMS HEALTH
Europaplatz 3 / Stiege 4 / 6. Stock
1150 Wien
,Austria
Tel: +43 (0) 1 78 00 2
Web: http://www.imshealth.com/portal/site/ims
IMS Health is a leading provider of information, services and technology for the healthcare industry, covering markets in 100+ countries around the world. A market leader for more than 25 years. IMS blends industry expertise and advanced technology to deliver the most accurate perspectives and in-depth analytics on healthcare dynamics. Actionable insights, powered by superior information assets, are tuned to clients’ precise requirements.
The IMS team counts up to 5.000 employees worldwide. The Austrian affiliate serves their clients with a team of 24 seasoned people and has the pleasure to cooperate with over 850 doctors, 280 pharmacies, 120 hospitals and nearly all operating wholesalers.
IMS continuously innovates to keep pace with a global healthcare environment that is increasingly complex and interdependent. Whether the clients are decision makers in life sciences, payers, providers or policymakers, the analytical, commercial IMS services and consulting capabilities are key to competitive advantage — and to achieving high-quality, cost-effective healthcare.
Dr. Rumler, what is your assessment of the subsidiary’s current strengths and weaknesses, after three and half years of tenure? Pfizer currently ranks second in the overall pharmaceutical market in…
Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first…
Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed…
Just like other European countries, Austria is in the search for meaningful savings in healthcare. Austria’s increasingly price sensitive pharma market is seeing the rise of generic medicines gaining market…
Whereas most General Managers are exposed to different countries during their professional career, you have chosen to dedicate yours to the Austrian market. What is it in this country so…
You have been General Secretary of PHARMIG since 2004 and have witnessed the market’s development over the past 8 years. What have been the most important changes since you started…
See our Cookie Privacy Policy Here
